VIC Session – Evaluating Exit Strategy: Options, Getting Ready and When is the Right Time to Act?

***Registration for this event is now closed, to join please email laurabacchus@onenucleus.com***

Raising funds or executing an M&A transaction is a significant milestone for any Life Science business. It can be challenging to know where to focus your time to best prepare yourself, your team and your business for investment or sale.
  
During this talk, the M&A specialists in EY’s Life Sciences & Healthcare Strategy & Transactions team will be giving an online presentation covering:
 
•    An overview of various exit options for shareholders of Life Sciences businesses (e.g. trade sale, sale to Private Equity or merger);
•    Highlight the drivers of M&A activity and impact of COVID-19 on Life Sciences M&A in attracting investment from around the globe;
•    Discuss the drivers of achieving a premium valuation and de-mystify the factors that have an influence on valuation;
•    Outline how to prepare for Life Sciences M&A deals, such as the due diligence process and other preparation considerations;
•    Briefly talk about how EY can work with entrepreneurs, start-up and scale-up Life Sciences businesses to support them to achieve their longer-term strategic objectives.

This should appeal to any Life Science entrepreneur, founder, start-up or scale-up to help them prepare for (and execute) their fundraising and M&A transactions.

Agenda
11.00 - Welcome
11.05 - Evaluating Exit Strategy Options, Getting Ready and When is the Right Time to Act?
Laura Segert, Partner, EY
Francesca Saunders, Manager Corporate, Finance, EY
Luca Costanzo, EY
11.45 - Q&A
12.00 - Close
 
As part of EY’s presentation there will be time available for you to ask questions and talk through challenges or success stories you have encountered yourself. 

Attendance: Free and open to all